Effects of various regimens of famotidine or an antacid on nilotinib pharmacokinetics in volunteers

Trial Profile

Effects of various regimens of famotidine or an antacid on nilotinib pharmacokinetics in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2013

At a glance

  • Drugs Nilotinib (Primary) ; Aluminium hydroxide/magnesium hydroxide; Famotidine
  • Indications Acute lymphoblastic leukaemia; Chronic myeloid leukaemia; Gastritis; Gastro-oesophageal reflux; Gastrointestinal stromal tumours; Malignant melanoma; Peptic ulcer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top